Sensitive enzymatic assay for erythrocyte creatine with production of methylene blue.
We developed a new, highly sensitive enzymatic method for quantifying creatine in erythrocytes, which comprises creatine amidinohydrolase, sarcosine oxidase, and peroxidase. In the present method, an N-methylcarbamoyl derivative of methylene blue, 10-N-methylcarbamoyl-3,7-bis(dimethylamino)phenothiazine (MCDP), was used as a sensitive chromogenic compound. Potassium ferrocyanide was used to prevent nonspecific oxidation of MCDP. The enzymatic method exhibited good analytical performance: precision, within-run CVs <1.0% and between-day CVs <2.0%; average analytical recovery, 99.3% +/- 1.8%; detection limit, 1.0 micromol/L in hemolysate; and linearity, at least up to 500 micromol/L as creatine concentration in hemolysate. Excellent agreement was observed between the present method (y) and HPLC (x), y = 1.029x - 0.002 micromol/g hemoglobin, r = 0.9998, S(y/x) = 0.053 micromol/g hemoglobin (n = 110). No significant interference was produced by various compounds, including guanidino compounds, amino acids, and reducing materials. The reference intervals (mean +/- 2 SD) for erythrocyte creatine obtained from 60 males and 60 females were (in micromol/g hemoglobin) 1.18 +/- 0.52 (0.66-1.70) for males and 1.35 +/- 0.49 (0.86-1.84) for females. Using this method, we documented changes in erythrocyte creatine in patients with various hemolytic conditions, including hemolytic anemia, liver cirrhosis, renal insufficiency, and chronic renal failure treated with hemodialysis with or without the administration of erythropoietin. We conclude that the use of MCDP allows sensitive measurement of erythrocyte creatine and that MCDP with potassium ferrocyanide can improve the sensitivity of assays that use peroxidase for detection of H2O2.
Department of Laboratory Medicine, Kochi Medical School, Nankoku, Japan. okumiyat/KMS@kochi-ms.ac.jp
T
T
Okumiya
Y
Y
Jiao
T
T
Saibara
A
A
Miike
K
K
Park
T
T
Kageoka
M
M
Sasaki
D000328:Adult; D000743:Anemia, Hemolytic / Q000097:blood; D002863:Chromogenic Compounds / Q000378:metabolism; D003124:Colorimetry; D004396:Coloring Agents / Q000378:metabolism; D003401:Creatine / Q000097:blood*; D004912:Erythrocytes / Q000378:metabolism*; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood; D008297:Male; D008751:Methylene Blue / Q000378:metabolism; D008875:Middle Aged; D010084:Oxidation-Reduction; D010089:Oxidoreductases, N-Demethylating; D009195:Peroxidase; D010640:Phenothiazines / Q000378:metabolism; D012016:Reference Values; D006435:Renal Dialysis; D051437:Renal Insufficiency / Q000097:blood / Q000628:therapy; D050879:Sarcosine Oxidase; D012680:Sensitivity and Specificity; D014512:Ureohydrolases
C062307:10-N-methylcarbamoyl-3,7-dimethylamino-10H-phenothiazine; D002863:Chromogenic Compounds; D004396:Coloring Agents; D010640:Phenothiazines; D009195:Peroxidase; D010089:Oxidoreductases, N-Demethylating; C494349:PIPOX protein, human; D050879:Sarcosine Oxidase; D014512:Ureohydrolases; C019944:creatinase; D003401:Creatine; D008751:Methylene Blue